Below, we use the new enrollment data to examine the major pharmacy chains’ position within the 27 major Part D plans that have preferred networks. As you will see, the big supermarket chains—Albertsons, Kroger, and Publix—outpaced the big three drugstore chains and Walmart.
Pharmacies continue to sacrifice margin for store traffic. Don’t expect that to change—especially given the notable failure of the independents-only Indy Health Part D plan.
D IS FOR DATA
Last fall, we published the following three-part series on the 2021 Medicare Part D market:
For 2021, we have examined the 27 Part D plans offered by nine major companies. There are 26 major multi-regional Part D plans with preferred cost sharing pharmacy networks and 1 smaller plan (Elixir RxSecure). These companies operate 888 regional PDPs, which amounts to 92% of total regional PDPs. For each plan, we identified the preferred status of seven large retail chains.
For the plans with preferred pharmacy networks, we also identified the preferred status of the largest seven retail chains. The open enrollment period for 2021 ran from October 15, 2020, to December 7, 2020. We used these data on enrollment: Medicare Advantage/Part D Contract and Enrollment Data. The figures include enrollment as of the February 1, 2021 payment, so they reflect 2021 trends. For each plan, we summed the total February enrollment.
Note that we examined stand-alone PDPs. A smaller share of Medicare Advantage Prescription Drug (MA-PD) plans have preferred networks. MA-PD plans account for a growing share of enrollment, so we intend to include these plans in future analyses.
P IS FOR PREFERRED
Based on the new enrollment figures, the 27 plans with preferred networks enrolled 19.6 million people. That equates to 99% of the total beneficiaries enrolled in a stand-alone Part D plan, and 93% of the total beneficiaries enrolled in a stand-alone Part D plan with a preferred network.
We used the enrollment data to measure each chain’s position in the 2021 preferred networks based on the open enrollment period. The chart shows the total enrollment in the plans for which each chain is a preferred pharmacy. For comparison, we include data from the 2020 open enrollment period.
[Click to Enlarge]
Here are the key trends for the largest retail chains:
- CVS pharmacy. For 2021, CVS Health’s retail pharmacies are preferred in plans that enrolled 9.6 million people. This figure is comparable to its 2020 position.
- Walgreens. Based on the initial enrollment data, 7.8 million people signed up for the 12 plans in which Walgreens is a preferred pharmacy. This marks an improvement over the chain’s position in previous years. Walgreens is the only national chain in the AARP MedicareRx Walgreens plan, though that plan’s enrollment declined by 5% for 2021.
- Walmart. Walmart is a preferred pharmacy in 19 of the 27 major preferred cost sharing networks. Consequently, 13.8 million people are enrolled in plans with Walmart as a preferred pharmacy. That’s comparable to the 2020 figure, but it’s a significant increase in its position in 2019, when a comparatively low 8.4 million enrolled in plans for which Walmart was a preferred pharmacy. Walmart is one of three national chains in the Humana Walmart Value Rx Plan. (Kroger and Publix are also preferred.) That plan’s enrollment grew significantly from 2020.
- Rite Aid. For 2021, Rite Aid remains far behind its drugstore peers. Fewer than 1 million people enrolled in plans that have Rite Aid as a preferred pharmacy for 2021. Enrollment in the company’s Elixir plans dropped by 6% from 2020 enrollment.
- Kroger/Albertsons/Publix. These supermarket chains benefited from gaining access as preferred pharmacies in the SilverScript and Humana plans. For 2021, Kroger is a preferred pharmacy in 24 major national plans that enrolled 17.6 million people—a significant jump from the 2020 figure. Albertsons is a preferred pharmacy in plans that enrolled 10.8 million people—more than twice the 2020 figure. Publix is a preferred pharmacy in plans that enrolled 15.8 million people.
E IS FOR ECONOMICS
Chain pharmacies are trying to remain competitive and attract consumers in a saturated retail dispensing market. Pharmacies therefore have incentives to reduce their margins in exchange for growing (or even maintaining) market share. A pharmacy’s cost structure encourages such competition for network position. (See my discussion of pharmacy prescription profits in Section 11.2.1. of my forthcoming report.) Consequently, the reduction in pharmacy profits—via lower reimbursement from plans and/or higher direct and indirect remuneration (DIR) payments by pharmacies—remains the primary source of cost savings from narrow networks.
Pharmacy owners should be realistic about overturning this system. Consider the sad fate of Indy Health Insurance Company, the new Part D plan sponsor that launched for 2021. As I noted in October, an unknown number of pharmacy owners funded Indy Health. It offers two plans (EliteRx and SaverRx), but only in five states. Both chains and independents are in-network, though only independent pharmacies are preferred.
Alas, Indy Health enrolled only about 37,000 seniors in its two plans. That’s about 0.2% of seniors. Despite glimmers of good news and the benefits from vaccination, I suspect that this year will not prove to be delightful for pharmacy economics.
CORRECTION: An earlier version of this article incorrectly stated that Walmart is the only national chain in the Humana Walmart Value Rx Plan. As we noted in October, Kroger and Publix have been added as preferred pharmacies for 2021.